Opinion

Most traders stare at indicators that summarise the past. Moving averages, RSI, MACD, and similar tools can help with structure, but they rarely show the most useful thing on the chart: where serious size has actually traded. Volume Profile and VWAP bring the focus back to the auction. They show where price was accepted, where it was rejected, and where large participants may have built or defended positions. That does not mean they reveal every institutional footprint with c

Most traders can explain their strategy better than they can explain their own behaviour. They know the setup, the entry trigger, the stop level, and the target. Yet the real damage often happens in the space between plan and action. A trade is entered too early because waiting feels uncomfortable. A winner is closed too soon because giving back profit feels unbearable. A losing position is held because accepting the loss feels personal. A trading journal helps because it tur

The dollar is setting the pace, and the rest of FX is reacting. When the US Dollar Index, or DXY, starts sweeping intraday highs and lows, EUR/USD and GBP/USD rarely sit still for long. That is exactly the kind of session intraday traders need to treat with care: fast repricing, sharp reversals, and liquidity grabs around obvious technical levels. Today’s FX tape is being driven by a familiar mix. Central bank messaging is shaping rate expectations. Trade headlines are feedin

In the summer of 1920, people queued in Boston to hand their savings to a man who promised something no ordinary bank could touch: 50% profit in 45 days. Not in years. Not even in months. In a month and a half. Charles Ponzi looked like proof that the impossible had become practical. Early investors received their money back with the promised profit. Newspapers printed his name. Crowds grew. The scheme seemed to be powered by some clever crack in the world economy, a trick in

Jesse Livermore became famous for doing the thing most people cannot bear to do. When markets were euphoric, he sold. When crowds believed prices could only rise, he watched for weakness. Twice, in 1907 and 1929, he stood on the wrong side of public optimism and the right side of history. The rewards were staggering. Livermore made fortunes from crashes, including a reported fortune of around $100 million after the 1929 collapse, a sum worth vastly more in modern terms. He wa

A trading strategy can look brilliant on five cherry-picked charts and still fail the moment real money is involved. Backtesting is the filter between an interesting idea and a tradeable system, but only if it is done with discipline. Good backtesting answers a practical question: would this strategy have had a positive expectancy under realistic market conditions? That means testing clear rules, using clean data, accounting for costs, and resisting the urge to keep adjusting

Bond traders are sending a clear message: money is getting more expensive again, and equity markets are adjusting in real time. The immediate move in US Treasury yields is not just a fixed-income story. It is changing how institutions value future earnings, how they rank sectors, and how much risk they are willing to hold into the next few trading sessions. When the US 10-Year yield firms while the 2-Year yield stays elevated, speculative growth stocks lose some of their shin

In the summer of 1720, London developed a fever. One could feel it in coffee houses, clubs, drawing rooms, and the corridors of Parliament. Fortunes seemed to rise by the hour. Servants whispered about shares. Dukes compared subscription prices. Members of Parliament, bishops, poets, merchants, and courtiers all watched one company as if it had discovered a new law of nature. The company was the South Sea Company. Its promise was dazzling: access to trade with Spanish America

A bad trade often starts long before the order ticket opens. It starts with a glance at a chart, a restless hand, and the thought that something is about to happen without you. Overtrading rarely feels reckless in the moment. It feels like staying alert. It feels like fixing a previous mistake. It feels like grabbing an opportunity before it disappears. That is what makes it dangerous. The real problem is not only the market. It is the loop between boredom, stress, dopamine,

The warning signs were there long before the collapse. The numbers looked too perfect. The language was too complex. The profits appeared before the cash arrived. The debt seemed to vanish into structures few outsiders could explain. For years, Enron sold Wall Street a story of genius. It was no longer just a pipeline company. It was a new kind of energy trader, a technology pioneer, a market-maker for the modern age. Analysts praised it. Executives boasted about it. Investor

Commodities are trading like a macro stress test today. Gold is trying to price risk. Crude oil is reacting to supply headlines and geopolitical risk. Major agricultural contracts are caught between weather, export demand, and the US dollar. The common thread is simple: the dollar is setting the speed limit. A firmer dollar tends to cap rallies in dollar-priced commodities, especially gold and grains. Oil can resist that pressure when supply risk is strong enough, but even cr

Silicon carbide (SiC) is the undisputed future of high-power electrification. As traditional silicon chips reach their physical limits, SiC wide-bandgap semiconductors are stepping in to power electric vehicles (EVs), renewable energy grids, and next-generation AI data centers. Standing at the absolute center of this materials revolution is Wolfspeed, Inc. (NYSE: WOLF). Trading at $28.72 with a market capitalization of $1.52 billion, Wolfspeed is one of the most polarizing b

A trader can be right most of the time and still lose money. Another can be wrong more often than right and still grow an account steadily. The difference is not prediction. It is position sizing, risk control, and the maths behind risk to reward. If a trader wins 40% of trades but makes three times more on winners than they loses on losers, the account can grow. If another trader wins 70% of trades but keeps taking small profits and allows a few losses to become huge, the ac

A trader can follow a sound strategy in the morning and still make poor decisions by the afternoon. The market may not have changed much. The edge may still be there. What changed is the trader’s brain. Burnout in trading often hides behind normal-sounding habits. Watching one more candle. Checking one more timeframe. Staying exposed because “something might happen”. Over time, that constant pressure drains the mental systems needed for judgement, patience and self-control. T

Biotech investing is often a binary bet on clinical trials. However, BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) has fundamentally rewritten its story. Trading at $8.47 with a market capitalization of $2.16 billion, BCRX has successfully crossed the chasm from a cash-burning R&D shop to a profitable, self-sustaining rare disease powerhouse. For investors looking at the company today, the thesis has shifted from speculative pipe-dreams to core operational execution. Driven by

Mega-cap technology earnings are doing more than moving single stocks. They are setting the short-term tone for the whole risk market, from the Nasdaq and global tech funds to Bitcoin, Ethereum and retail sector positioning. The immediate link is clear enough. When the largest technology firms deliver reports that confirm demand for cloud computing, artificial intelligence infrastructure, digital advertising, semiconductors or consumer devices, tech indices tend to catch a bi